Kotak Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 0.9 %Nav, as on 10-10-2025

  • Previous Nav

  • Net Change on 10-10-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty Healthcare Index - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 4.06 27.90 20.00 1.87 6,226.82
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 -0.98 22.55 17.28 2.11 1,295.83
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 1.31 24.52 17.10 2.26 1,096.95

Fund Holdings as on 30-September-2025

  • SUN PHARMACEUTICAL INDUSTRIES LTD.

  • Max Healthcare Institute Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Cipla Ltd.

  • Divis Laboratories Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Fortis Healthcare India Ltd

  • Lupin Ltd.

  • JUBILANT PHARMOVA LIMITED

  • KRISHNA INSTITUTE OF MEDICAL

  • Gland Pharma Limited

  • ASTER DM HEALTHCARE LTD

  • ANTHEM BIOSCIENCES LTD

  • Dr.Reddy's Laboratories Ltd.

  • MANKIND PHARMA LTD

  • Alkem Laboratories Ltd.

  • Triparty Repo

  • Ami Organics Ltd

  • Glenmark Pharmaceuticals Ltd

  • Aurobindo Pharma Ltd.

  • Ajanta Pharma Ltd.

  • SAI LIFE SCIENCES LIMITED

  • LAXMI DENTAL LIMITED

  • Marksans Pharma Ltd

  • INNOVA CAPTABS LTD

  • Zydus Lifesciences Ltd.

  • Krsnaa Diagnostics Ltd

  • ORCHID PHARMA LIMITED

  • YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD

  • RAINBOW CHILDRENS MEDICARE LTD

  • HIKAL LTD

  • Net Current Assets/(Liabilities)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Equity

View More

About Kotak Healthcare Fund

Scheme Analysis

Kotak Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Kotak Mahindra Mutual Fund. It was launched on 11-Dec-2023 and currently has an AUM of ₹464.13 crore. Kotak Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty Healthcare Index - TRI as secondary index.

The NAV of Kotak Healthcare Fund ended up ₹0.12(0.9%)yesterday to ₹13.613.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD., and

The Kotak Healthcare Fund is managed by Abhishek Bisen and Shibani Kurian.

Fund House Contact

27 BKC, C-27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051

+91 (22) 66384400
mutual@kotak.com
+91 (22) 66384455